by Talking Medicines | Jun 22, 2022
Global Business Report (GBR) have recently published “United States Life Sciences 2022” Report. It was published in partnership with BioNJ, Biocom California and CPHI. Jo Halliday ,CEO was asked to contribute to the report on the transformational...
by Talking Medicines | Apr 25, 2022
April 22nd marked the 52nd anniversary of ‘Earth Day’, founded in 1970 by US Senator for Wisconsin Gaylord Nelson, upon witnessing the devastating effects of a 1969 tanker oil spill in Santa Barbara. This action is widely attributed with triggering the environmental...
by Talking Medicines | Feb 25, 2022
Since everyone seems to be living their lives online these days, it makes sense this is where to find out what patients are really saying about their medicines. Now, U.K.- and New Jersey-based company Talking Medicines has developed an AI platform called PatientMetRx®...
by Talking Medicines | Feb 2, 2022
Talking Medicines, the world’s first Artificial Intelligence (AI) driven patient intelligence company designed to meet the needs of Pharma, has closed a £1.5 million funding round to support its ambitions plans for expansion into the US. Boston based life science...
by Talking Medicines | Aug 30, 2021
The team at Talking Medicines are delighted to have published an academic paper on the methodologies behind the classification of the patient voice by Alex et al. BMC Med Inform Decis Mak (2021) 21:244. This is part of the R&D work that has been completed in the...
by Talking Medicines | Jul 30, 2021
Talking Medicines partners with Closing Delta to help pharma accelerate digital transformation Data insights firm Talking Medicines, specialist in AI driven ‘social intelligence’ for the pharmaceutical industry, has formed a strategic partnership with digital...
